NEWARK, Del, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The global fructosamine test market was valued at around US$ 266.3 million in 2023 and is poised to exhibit a CAGR of 3.8% during the forecast period.

Please provide your email address to receive an email when new articles are posted on . Fructosamine can be a good glycemia screening tool and elevated levels can have a predictive role for ...

Objective—The glycation gap (the difference between measured A1C and the value predicted by regression on fructosamine) is stable and is associated with microvascular complications of diabetes but has ...

Monitoring glucose levels is imperative for diabetes patients, but for some the standard Hemoglobin A1c (HbA1c) test is not valid. Researchers have determined that the fructosamine tests and a novel ...

PHILADELPHIA (Nov.16, 2017) - Researchers identified a new way to lower the risk of complications after joint surgery, using a simple blood test. Patients with diabetes are more likely to need joint ...

(HealthDay News) – Fructosamine and glycated albumin are markers of glycemic control that may complement hemoglobin A1c (HbA1c) in identifying risk of diabetes and its complications, according to ...

The global fructosamine reagents market is expected to witness significant growth over the forecast period owing to increasing adoption of the fructosamine reagents for assays. By disease type, the ...

The global fructosamine test indutry was valued at around USD 266.3 million in 2023 and is poised to exhibit a CAGR of 3.8% during the forecast period. Accordingly, total market valuation is expected ...